Compare Illumina, Inc. (ILMN) vs Opendoor Technologies Inc (OPEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Opendoor Technologies Inc — how do they compare? Illumina, Inc. trades at $189.96 (market cap $27.94B), while Opendoor Technologies Inc trades at $4.38 (market cap $4.29B). The key difference: Illumina, Inc. is far larger — about 6.5× Opendoor Technologies Inc's market cap, and Illumina, Inc. is trading nearer its 52-week high, Opendoor Technologies Inc nearer its low. Which is the better fit depends on your goals.
| ILMN | OPEN | |
|---|---|---|
Market Cap | $27.94B | $4.29B |
Sector | Health | Real Estate |
52-Week High | $194.33 | $10.52 |
52-Week Low | $91.00 | $1.84 |
Enterprise Value | $29.33B | $4.63B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
Opendoor Technologies (OPEN) trades at $4.415, down 1.89% on the day, reflecting ongoing market skepticism despite recent operational improvements. The stock shows a bearish technical trend with mixed oscillators, while fundamentals reveal persistent losses with a -35.25% net income margin and negative ROE of -173.61%. Revenue has declined from $15.6B in 2022 to $4.37B in 2025, though cash flow turned positive in 2025 at $538M. Recent news highlights CEO focus on housing market challenges and India operations closure to prioritize AI integration.
The outlook remains cautious with high debt and profitability concerns offset by low P/S valuation and analyst 'Hold' consensus. Key risks include interest rate sensitivity and execution of the Opendoor 2.0 model, while potential upside hinges on margin stabilization and seasonal housing rebounds. Investors face a high-risk, speculative opportunity amid structural shifts in real estate tech.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Opendoor Technologies Inc
Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →
